Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT03062904
Eligibility Criteria:
Inclusion Criteria:
All the volunteers will:
* be between 18 and 35 years/old
* be male (because of binding thoracic, more difficult to realize and more uncomfortable in the female subjects)
* have to understand French
* have to be affiliated to the social security
* have to be "non smokers, or having never smoked"
* have to have read and have understood the information record
* have to have signed the informed consent
* have to not to be involved in a former scientific study.
* abnormal PFT (at least one value below the lower limit of normal)
* Abnormal chest radiography
* Abnormal ECG
Exclusion Criteria:
* Chronic pathology
* Long-standing treatments, recent vaccination (\< 3 weeks), recent bronchitis (\< 3 weeks)
* Cardio-respiratory diseases, in particular: asthma, COPD, previous pneumothorax, hemoptyses, acute coronary syndrome, uncontrolled and/or untreated cardiac arrhythmia, bradycardia (\<55bpm), arterial hypertension (diastolic\>95mmHg, systolic\>150mmHg),
* Current abdominal disease (clinical or known hepatomegaly, irritable bowel syndrome, etc…), gastro-oesophageal reflux
* BMI \< 18 and \> 26
* Disorder of coagulation (and anticoagulant treatment), frequent epistaxis
* Porphyrae
* Epilepsy, Cerebrovascular accident (stroke or transient ischemic attack) \< 3 months
* Severe hepatic Insufficiency
* Glaucoma
* Benign Prostatic Hypertrophy
* Allergy: latex, lidocaine, salbutamol, ipratropium or parasympathomimetic agents
* Current allergic rhino-conjunctivitis
* History of previous oedema of Quincke or anaphylactic shock
* Aneurism of the aorta, cerebral aneurism or another arterial aneurism
* Myasthenia
* Thyroid disorders
* Protected underage child and adults
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT03062904
Study Brief:
Protocol Section:
NCT03062904